Q3 2024 Genomma Lab Internacional SAB de CV Earnings Call Transcript
Key Points
- Sales increased by 15.9%, driven by strong performance in major markets such as Mexico, Brazil, Argentina, and the US.
- Gross margin improved by 184 basis points, reaching 64.3%, indicating successful productivity initiatives and manufacturing efficiencies.
- EBITDA expanded by 245 basis points to 23.7%, reflecting effective cost management and operational improvements.
- Net income surged by 78.1%, with earnings per share growing by 81.6%, showcasing strong financial performance.
- Cash flow generation reached a record high of MXN2,404 million, representing a 68.1% increase, highlighting robust cash management.
- Challenges persist in the skincare category, with expectations to resolve issues by Q2 2025.
- Blades and razors face issues related to Celine, although sellout remains healthy in Mexico.
- Headwinds were encountered in Peru and Chile, impacting overall regional performance.
- Receivables increased by seven days year over year, and days payable outstanding decreased by seven days, indicating potential cash flow management challenges.
- Forex was a headwind in Argentina and Brazil, affecting financial results in these regions.
Are subject to risks and uncertainties that could cause actual results to differ materially. They are also based on assumptions as of today and the company undertakes no obligation to update them as a result of new information or future events. Let me now turn the call over to Marco.
Good morning, everyone, and thank you, Chris. I am thrilled to share our strong Q 3 2024 results.
This quarter, we have seen substantial progress across all key metrics surpassing last year's results. Previous periods and our internal targets sales increased by 15.9% driven by excellent performance in major markets such as Mexico, Brazil, Argentina and the US gross margin improved by 184 basis points reaching 64.3%.
EBITDA expanded by 245 basis points reaching [23.7%] fueled by our productivity initiatives and manufacturing efficiencies.
Net income surged by 78.1% and earnings per share
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
